Exagen 10% Owner Jorey Chernett Reports Sale of Common Shares Worth $69,167.10
- Exagen 10% owner Jorey Chernett reported direct beneficial ownership of 2,625,625 common shares in a Form 4 dated November 10, 2026.
- Chernett sold 11,265 common shares at $6.14 per share on November 6, 2026.
- He purchased 8,500 common shares at $6.35 per share on November 9, 2026.
- A November 10, 2026, purchase added 7,085 common shares at $5.26 per share.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exagen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000921895-26-003021), on November 10, 2026, and is solely responsible for the information contained therein.